Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
186.4 INR | +0.24% | -6.92% | -10.15% |
05-09 | Transcript : Nath Bio-Genes Limited, Q4 2024 Earnings Call, May 09, 2024 | |
05-08 | Nath Bio-Genes Limited Recommends Dividend for Financial Year 2023-24 | CI |
Sales 2022 | 2.78B 33.34M 45.57M | Sales 2023 | 3.01B 36.1M 49.34M | Capitalization | 2.68B 32.15M 43.94M |
---|---|---|---|---|---|
Net income 2022 | -673M -8.06M -11.02M | Net income 2023 | 350M 4.19M 5.73M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.64M 14.54M | Net Debt 2023 | 672M 8.05M 11M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 38.47% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | +0.24% | ||
1 week | -6.92% | ||
Current month | -9.67% | ||
1 month | -0.75% | ||
3 months | -12.68% | ||
6 months | -5.69% | ||
Current year | -10.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 18-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director/Board Member | 60 | 12-10-09 | |
Director/Board Member | 42 | 15-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 186.4 | +0.24% | 48 848 |
24-05-13 | 185.9 | -1.93% | 37,601 |
24-05-10 | 189.6 | -2.07% | 62,212 |
24-05-09 | 193.6 | -5.29% | 73,531 |
24-05-08 | 204.4 | +2.07% | 60,142 |
Delayed Quote NSE India S.E., May 14, 2024 at 07:49 am
More quotes1st Jan change | Capi. | |
---|---|---|
-10.15% | 42.3M | |
+14.36% | 3.36B | |
-95.58% | 1.61B | |
-2.07% | 1.57B | |
-0.33% | 1.28B | |
-7.81% | 1.24B | |
-.--% | 1.22B | |
-11.06% | 1.22B | |
0.00% | 1.19B | |
+9.15% | 1.18B |
- Stock Market
- Equities
- NATHBIOGEN Stock